Nuvera are experts in optimizing the design and build of seamless patient and HCP treatment experiences. This expertise will enhance Ashfield Engage’s Patient Solutions capabilities and create an end-to-end strategic offering across their client’s product lifecycles.
Founded in 2010, Nuvera has partnered with a multitude of larger pharmaceutical and emerging biotech commercial teams for over a decade, helping to develop industry leading patient support strategies and capabilities. Bourne Partners served as exclusive financial advisor to Nuvera in the structuring and negotiation of this transaction.
Ashfield Healthcare partners with clients across Advisory, Healthcare Communications, Commercial, Patient Solutions and Medical Affairs to build creative, scalable and tailored health solutions to address their client’s challenges and deliver positive outcomes for patients.
Nuvera LLC is a strategic consulting company focused exclusively on the rare disease and specialty therapeutics markets, based in New Jersey. Nuvera is dedicated to helping its clients design and enable seamless treatment experiences and envision a world of simple, streamlined treatment experiences that alleviate the burden of using specialized therapies and accelerate treatment success for patients and providers.
Ashfield comprises of three integrated business units: Ashfield Advisory, Ashfield Engage and Ashfield Health. Together, the Ashfield team uses imagination, strategy and action to redefine and deepen client partnerships, reimagine health and improve lives.
Ashfield has curated its business through the acquisition of 22 companies and is committed to offering streamlined services to best meet its clients’ needs.
Takeaway: Ashfield partners with clients to build creative, scalable and tailored health solutions to address their client’s challenges and deliver positive outcomes for patients